Loading organizations...
Loading organizations...
Innovative drugs targeting oxygen radicals for chronic disease treatment.
Genkyotex has raised $65.9M across 3 funding rounds.
Genkyotex has raised $65.9M in total across 3 funding rounds.
Genkyotex has raised $65.9M in total across 3 funding rounds.
Genkyotex's investors include BioMedPartners, Claudio Nessi, VI Partners, Eclosion, Vesalius Biocapital, Jesús Martin-Garcia, MP Healthcare Venture Management.
Genkyotex has raised $65.9M across 3 funding rounds. Most recently, it raised $19.7M Series D in January 2015.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 7, 2015 | $19.7M Series D | BioMedPartners, Claudio Nessi, VI Partners | Eclosion, Vesalius Biocapital |
| Jul 9, 2012 | $25.6M Series C Extension | Jesús Martin-Garcia, MP Healthcare Venture Management, Vesalius Biocapital | |
| May 25, 2011 | $20.6M Series C | Eclosion, MP Healthcare Venture Management, Vesalius Biocapital |